SKYRIZI and RINVOQ Data Highlight Long-Term IBD Outcomes at UEGW 2026
AbbVie announced the presentation of 20 new scientific abstracts at the 2026 United European Gastroenterology Week in Barcelona, Spain, highlighting long-term and real-world outcomes for SKYRIZI and RINVOQ in treating ... Read More